Home › NDC Lookup › RxCUI directory › RxCUI 904870

168 HR buprenorphine 0.01 MG/HR Transdermal System — RxCUI 904870

RxNorm drug concept · Semantic clinical drug
RxCUI 904870 Semantic clinical drug · SCD ● Current RxNorm concept 34 FDA products 34 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI904870
Official name168 HR buprenorphine 0.01 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbuprenorphine 10 MCG/HR 7 Day Transdermal System; buprenorphine 10 MCG/HR Weekly Transdermal Patch
FDA products mapped34
Package NDCs mapped34
Reported Medicaid activity (SDUD)105,289 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Buprenorphine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is for severe, ongoing pain that needs around-the-clock opioid treatment when other options have not worked or are not enough. It is not for occasional, as-needed pain.
  • Put one patch on clean, intact skin and leave it on for 7 days. Do not cut it or use a damaged one. Wait at least 3 weeks before using the same spot again.
  • No. Heat makes your skin absorb more medicine, which could lead to overdose. Avoid heating pads, electric blankets, saunas, hot tubs, hot water and long sun exposure over the patch...
  • The most common are nausea, headache, dizziness, constipation, sleepiness, vomiting and dry mouth. You may also have itching, redness or rash at the patch site. Call right away for...
📖 Read our full Buprenorphine Transdermal Patch guide →

🕸️ Concept Web — How 168 HR buprenorphine 0.01 MG/HR Transdermal Syst... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 168 HR buprenorphine 0.01 MG/HR Transdermal System RxCUI 904870

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Buprenorphine 1819
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • BuTrans 904871
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Buprenorphine Transdermal System 1806212
    • Buprenorphine Topical Product 1151364
    • Buprenorphine Transdermal Product 1295269
    • Buprenorphine Transdermal System [BuTrans] 1806214
    • BuTrans Topical Product 1168053
    • BuTrans Transdermal Product 1296477
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Buprenorphine 0.01 MG/HR SCDC · 904869
  • Buprenorphine Transdermal System SCDF · 1806212
  • Buprenorphine Topical Product SCDG · 1151364
  • Buprenorphine Transdermal Product SCDG · 1295269

Brand-Name Concepts

📦 FDA Products & Package NDCs

34 products · 34 package NDCs
34 package NDCs map to RxCUI 904870 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-3239-40 4 POUCH in 1 CARTON (0093-3239-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Teva Pharmaceuticals USA, Inc. 2021-12-27
00093-3656-40 4 POUCH in 1 CARTON (0093-3656-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Teva Pharmaceuticals USA, Inc. 2018-11-26
00093-3657-40 4 POUCH in 1 CARTON (0093-3657-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Teva Pharmaceuticals USA, Inc. 2018-11-26
00093-3658-40 4 POUCH in 1 CARTON (0093-3658-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Teva Pharmaceuticals USA, Inc. 2018-11-26
00093-3659-40 4 POUCH in 1 CARTON (0093-3659-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Teva Pharmaceuticals USA, Inc. 2018-11-26
03215-1521-04 4 POUCH in 1 CARTON (3215-1521-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine Aveva Drug Delivery Systems Inc. 2023-11-01
03215-1522-04 4 POUCH in 1 CARTON (3215-1522-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine Aveva Drug Delivery Systems Inc. 2023-11-01
03215-1523-04 4 POUCH in 1 CARTON (3215-1523-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine Aveva Drug Delivery Systems Inc. 2023-11-01
03215-1524-04 4 POUCH in 1 CARTON (3215-1524-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine Aveva Drug Delivery Systems Inc. 2023-11-01
03215-1525-04 4 POUCH in 1 CARTON (3215-1525-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine Aveva Drug Delivery Systems Inc. 2023-11-01
42858-0353-40 4 POUCH in 1 CARTON (42858-353-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Rhodes Pharmaceuticals LLC 2017-07-05
42858-0493-40 4 POUCH in 1 CARTON (42858-493-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Rhodes Pharmaceuticals LLC 2017-07-05
42858-0586-40 4 POUCH in 1 CARTON (42858-586-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Rhodes Pharmaceuticals LLC 2017-07-05
42858-0750-40 4 POUCH in 1 CARTON (42858-750-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Rhodes Pharmaceuticals LLC 2017-07-05
42858-0839-40 4 POUCH in 1 CARTON (42858-839-40) / 1 PATCH in 1 POUCH / 1... Buprenorphine Rhodes Pharmaceuticals LLC 2017-07-05
47781-0406-04 4 POUCH in 1 CARTON (47781-406-04) / 1 PATCH in 1 POUCH (47... buprenorphine transdermal system Alvogen Inc. 2022-08-29
47781-0407-04 4 POUCH in 1 CARTON (47781-407-04) / 1 PATCH in 1 POUCH (47... buprenorphine transdermal system Alvogen Inc. 2022-08-29
47781-0408-04 4 POUCH in 1 CARTON (47781-408-04) / 1 PATCH in 1 POUCH (47... buprenorphine transdermal system Alvogen Inc. 2022-08-29
47781-0419-04 4 POUCH in 1 CARTON (47781-419-04) / 1 PATCH in 1 POUCH (47... buprenorphine transdermal system Alvogen Inc. 2022-08-29
50742-0372-04 4 POUCH in 1 CARTON (50742-372-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine INGENUS PHARMACEUTICALS, LLC 2023-11-01
50742-0373-04 4 POUCH in 1 CARTON (50742-373-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine INGENUS PHARMACEUTICALS, LLC 2023-11-01
50742-0374-04 4 POUCH in 1 CARTON (50742-374-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine INGENUS PHARMACEUTICALS, LLC 2023-11-01
50742-0375-04 4 POUCH in 1 CARTON (50742-375-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine INGENUS PHARMACEUTICALS, LLC 2023-11-01
50742-0376-04 4 POUCH in 1 CARTON (50742-376-04) / 1 PATCH in 1 POUCH / 1... Buprenorphine INGENUS PHARMACEUTICALS, LLC 2023-11-01
59011-0750-04 4 POUCH in 1 CARTON (59011-750-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0751-04 4 POUCH in 1 CARTON (59011-751-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0752-04 4 POUCH in 1 CARTON (59011-752-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0757-04 4 POUCH in 1 CARTON (59011-757-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0758-04 4 POUCH in 1 CARTON (59011-758-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
69238-1202-02 4 POUCH in 1 CARTON (69238-1202-2) / 1 PATCH in 1 POUCH / 1... Buprenorphine Amneal Pharmaceuticals NY LLC 2020-04-20
69238-1203-02 4 POUCH in 1 CARTON (69238-1203-2) / 1 PATCH in 1 POUCH / 1... Buprenorphine Amneal Pharmaceuticals NY LLC 2020-04-20
69238-1204-02 4 POUCH in 1 CARTON (69238-1204-2) / 1 PATCH in 1 POUCH / 1... Buprenorphine Amneal Pharmaceuticals NY LLC 2020-04-20
69238-1205-02 4 POUCH in 1 CARTON (69238-1205-2) / 1 PATCH in 1 POUCH / 1... Buprenorphine Amneal Pharmaceuticals NY LLC 2020-04-20
69238-1505-02 4 POUCH in 1 CARTON (69238-1505-2) / 1 PATCH in 1 POUCH / 1... Buprenorphine Amneal Pharmaceuticals NY LLC 2020-04-20
Observed labelers: Amneal Pharmaceuticals NY LLC (5) · Aveva Drug Delivery Systems Inc. (5) · INGENUS PHARMACEUTICALS, LLC (5) · Knoa Pharma LLC (5) · Rhodes Pharmaceuticals LLC (5) · Teva Pharmaceuticals USA, Inc. (5) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.